Instantánea de Innogenetics
Christiaan De Wilde
No hay datos suficientes para mostrar la aprobación del CEO
Apparently innovative work in genetic testing is spelled Innogenetics in any language. The biopharmaceutical company creates genetic, infectious disease, cancer, and neurological tests. Innogenetics' products include tests and genotyping profiles to identify conditions such as cystic fibrosis, HIV, hepatitis, and Alzheimer's disease. The company also provides biological manufacturing services (producing virus strains and proteins) for pharmaceutical firms and research labs. The firm's products are sold through subsidiaries and distributors in about 90 countries. The company was previously a unit of Belgium's Solvay, which was acquired by Abbott in 2010; Abbott sold Innogenetics to Japan's Fujirebio later that year.
